DK0923594T3 - Bromotiacumicinforbindelser - Google Patents

Bromotiacumicinforbindelser

Info

Publication number
DK0923594T3
DK0923594T3 DK97931411T DK97931411T DK0923594T3 DK 0923594 T3 DK0923594 T3 DK 0923594T3 DK 97931411 T DK97931411 T DK 97931411T DK 97931411 T DK97931411 T DK 97931411T DK 0923594 T3 DK0923594 T3 DK 0923594T3
Authority
DK
Denmark
Prior art keywords
bromothiacumicin
compounds
bromothiacumicin compounds
Prior art date
Application number
DK97931411T
Other languages
English (en)
Inventor
Jill E Hochlowski
Marianna Jackson
James B Mcalpine
Ronald R Rasmussen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0923594T3 publication Critical patent/DK0923594T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK97931411T 1996-07-12 1997-06-24 Bromotiacumicinforbindelser DK0923594T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/678,906 US5767096A (en) 1996-07-12 1996-07-12 Bromotiacumicin compounds
PCT/US1997/011064 WO1998002447A1 (en) 1996-07-12 1997-06-24 Bromotiacumicin compounds

Publications (1)

Publication Number Publication Date
DK0923594T3 true DK0923594T3 (da) 2003-02-10

Family

ID=24724791

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97931411T DK0923594T3 (da) 1996-07-12 1997-06-24 Bromotiacumicinforbindelser

Country Status (20)

Country Link
US (1) US5767096A (da)
EP (1) EP0923594B1 (da)
JP (1) JP2000515512A (da)
KR (1) KR100476799B1 (da)
CN (1) CN1149220C (da)
AR (1) AR007854A1 (da)
AT (1) ATE225364T1 (da)
AU (1) AU730839B2 (da)
BR (1) BR9710250A (da)
CA (1) CA2257984A1 (da)
CZ (1) CZ294843B6 (da)
DE (1) DE69716094T2 (da)
DK (1) DK0923594T3 (da)
ES (1) ES2186900T3 (da)
HU (1) HU224966B1 (da)
IL (1) IL127540A (da)
NZ (1) NZ333258A (da)
PT (1) PT923594E (da)
WO (1) WO1998002447A1 (da)
ZA (1) ZA975861B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105791A1 (en) * 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
JP2005534332A (ja) * 2002-07-29 2005-11-17 オプティマー ファーマシューティカルズ、インコーポレイテッド チアクマイシン生産
US7906489B2 (en) * 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
ES2395404T3 (es) * 2004-05-14 2013-02-12 Optimer Pharmaceuticals, Inc. Tratamiento de las enfermedades asociadas al uso de antibióticos
MX2007009196A (es) * 2005-01-31 2009-02-25 Optimer Pharmaceuticals Inc Compuestos macrocilicos de 18 miembros y analogos de los mismos.
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
CN102115757B (zh) * 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
MX2015011894A (es) * 2013-03-08 2015-12-15 Cipla Ltd Composiciones farmaceuticas para administracion rectal.
TR201815891T4 (tr) 2014-05-09 2018-11-21 Astellas Pharma Europe Ltd Tiakumisin bileşiği için tedavi rejimi.
MA42309A (fr) 2015-07-03 2021-03-24 Astellas Pharma Europe Ltd Nouveau composé de tiacumicine pour régime posologique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds

Also Published As

Publication number Publication date
CN1149220C (zh) 2004-05-12
HUP9903902A3 (en) 2001-06-28
CZ2899A3 (cs) 1999-03-17
AR007854A1 (es) 1999-11-24
ATE225364T1 (de) 2002-10-15
WO1998002447A1 (en) 1998-01-22
KR20000023662A (ko) 2000-04-25
CA2257984A1 (en) 1998-01-22
US5767096A (en) 1998-06-16
HU224966B1 (en) 2006-04-28
IL127540A0 (en) 1999-10-28
DE69716094D1 (de) 2002-11-07
ZA975861B (en) 1998-01-30
EP0923594A1 (en) 1999-06-23
AU730839B2 (en) 2001-03-15
BR9710250A (pt) 1999-08-10
NZ333258A (en) 2000-07-28
JP2000515512A (ja) 2000-11-21
PT923594E (pt) 2003-02-28
ES2186900T3 (es) 2003-05-16
KR100476799B1 (ko) 2005-03-16
HUP9903902A2 (hu) 2001-05-28
DE69716094T2 (de) 2003-06-05
IL127540A (en) 2004-05-12
EP0923594B1 (en) 2002-10-02
CZ294843B6 (cs) 2005-03-16
AU3504697A (en) 1998-02-09
CN1225096A (zh) 1999-08-04

Similar Documents

Publication Publication Date Title
ID19403A (id) Senyawa-senyawa heterosiklik
ID19609A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
ID19430A (id) Senyawa senyawa heterosiklik
BR9709230A (pt) Composto
BR9710352A (pt) Compostos piridilpirrole
BR9707051A (pt) Composto
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID18685A (id) Senyawa trisiklik tersubstitusi
EE9800430A (et) Uued ühendid
BR9705635A (pt) Compostos
BR9711205A (pt) Composto
DK0923594T3 (da) Bromotiacumicinforbindelser
DK0923562T3 (da) Substituerede p-trifluormethylphenyluraciler
DE69709659T2 (de) Halopropargyl-einschlussverbindungen
DE59707428D1 (de) Substituierte 1-methyl-3-benzyluracile
DE59711889D1 (de) Substituierte pyrazol-3-ylbenzazole
IS4932A (is) Ný efnasambönd
DE59712222D1 (de) Substituierte phenyluracile
DE59708674D1 (de) Substituierte 3-phenylpyrazole
ID17103A (id) Senyawa-senyawa sulfonamida
SE9600275D0 (sv) Compounds
SE9603300D0 (sv) Compounds
SE9603470D0 (sv) New compounds